Reven Pharmaceuticals
Reven Pharmaceuticals is a privately held, clinical-stage biopharmaceutical company founded in 1999 and headquartered in Broomfield, Colorado. Reven develops medicines from its proprietary RJX Technology platform - a patented, first-in-class intravenous composition of anti-oxidant and anti-inflammatory ingredients - and is advancing candidates for sepsis, multi-system inflammation, cytokine release syndrome, ARDS and vascular, oncology, CNS and ocular indications. Its lead candidate, Rejuveinix (RJX), completed a double-blind, placebo-controlled Phase 1 dose-escalation study in healthy volunteers and received FDA clearance of an Investigational New Drug application for the treatment of COVID-19. Reven publishes a corporate and investor website at reven.com covering its pipeline, modalities, clinical trials, expanded-access program and news, but operates no public developer program, API, SDK or machine-readable interface of any kind.
Reven Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Life Sciences, and Clinical Trials.
Reven Pharmaceuticals’ developer surface includes engineering blog, support, and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 4
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.